<VariationArchive RecordType="classified" VariationID="1801723" VariationName="NM_000743.5(CHRNA3):c.518_519del (p.Cys173fs)" VariationType="Deletion" Accession="VCV001801723" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-08-06" DateCreated="2022-12-11" MostRecentSubmission="2022-12-11">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1858915" VariationID="1801723">
      <GeneList>
        <Gene Symbol="CHRNA3" FullName="cholinergic receptor nicotinic alpha 3 subunit" GeneID="1136" HGNC_ID="HGNC:1957" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>15q25.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="78593052" stop="78620996" display_start="78593052" display_stop="78620996" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="78885393" stop="78913636" display_start="78885393" display_stop="78913636" Strand="-" />
          </Location>
          <OMIM>118503</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000743.5(CHRNA3):c.518_519del (p.Cys173fs)</Name>
      <CanonicalSPDI>NC_000015.10:78602122:ACA:A</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>15q25.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="15" Accession="NC_000015.10" start="78602123" stop="78602124" display_start="78602123" display_stop="78602124" variantLength="2" positionVCF="78602122" referenceAlleleVCF="TAC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="15" Accession="NC_000015.9" start="78894465" stop="78894466" display_start="78894465" display_stop="78894466" variantLength="2" positionVCF="78894464" referenceAlleleVCF="TAC" alternateAlleleVCF="T" />
      </Location>
      <OtherNameList>
        <Name>p.Cys173TyrfsTer11</Name>
      </OtherNameList>
      <ProteinChange>C173fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.10" sequenceAccession="NC_000015" sequenceVersion="10" change="g.78602124_78602125del" Assembly="GRCh38">
            <Expression>NC_000015.10:g.78602124_78602125del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000015.9" sequenceAccession="NC_000015" sequenceVersion="9" change="g.78894466_78894467del" Assembly="GRCh37">
            <Expression>NC_000015.9:g.78894466_78894467del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_016143.1" sequenceAccession="NG_016143" sequenceVersion="1" change="g.24172_24173del">
            <Expression>NG_016143.1:g.24172_24173del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000743.5" sequenceAccession="NM_000743" sequenceVersion="5" change="c.518_519del" MANESelect="true">
            <Expression>NM_000743.5:c.518_519del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000734.2" sequenceAccession="NP_000734" sequenceVersion="2" change="p.Cys173fs">
            <Expression>NP_000734.2:p.Cys173fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001166694.2" sequenceAccession="NM_001166694" sequenceVersion="2" change="c.518_519del">
            <Expression>NM_001166694.2:c.518_519del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001160166.1" sequenceAccession="NP_001160166" sequenceVersion="1" change="p.Cys173fs">
            <Expression>NP_001160166.1:p.Cys173fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_046313.2" sequenceAccession="NR_046313" sequenceVersion="2" change="n.720_721del">
            <Expression>NR_046313.2:n.720_721del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <FunctionalConsequence Value="Unknown function" />
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000743.5(CHRNA3):c.518_519del (p.Cys173fs) AND Urinary bladder, atony of" Accession="RCV002463880" Version="1">
        <ClassifiedConditionList TraitSetID="52023">
          <ClassifiedCondition DB="MedGen" ID="C5231389">Urinary bladder, atony of</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-12-11" MostRecentSubmission="2022-12-11">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="52023" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4312" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Urinary bladder, atony of</ElementValue>
                <XRef ID="MONDO:0008630" DB="MONDO" />
              </Name>
              <XRef ID="C5231389" DB="MedGen" />
              <XRef ID="MONDO:0008630" DB="MONDO" />
              <XRef Type="MIM" ID="191800" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5397033" SubmissionDate="2022-11-24" DateLastUpdated="2022-12-11" DateCreated="2022-12-11">
        <ClinVarSubmissionID localKey="SUB12326571" submittedAssembly="GRCh38" title="SUB12326571" />
        <ClinVarAccession Accession="SCV002754496" DateUpdated="2022-12-11" DateCreated="2022-12-11" Type="SCV" Version="1" SubmitterName="Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics" OrgID="505565" OrganizationCategory="other" OrgAbbreviation="FRIGE - IHG" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>A heterozygous two base pair deletion in exon 5 of the CHRNA3 gene that results in a frameshift and premature truncation of the protein 11 amino acids downstream to codon 173 was detected. This variant has not been reported in the 1000 genomes and gnomAD databases. The in silico predictions of the variant is damaging by MutationTaster2. The reference codon is conserved across species. The reference codon is conserved across species. In summary, the variant meets our criteria to be classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">X-linked recessive inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">20</Age>
              <Age Type="maximum" age_unit="years">29</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <NamePlatform>Illumina sequencing platform</NamePlatform>
              <TypePlatform>Next-generation sequencing</TypePlatform>
              <Description>DNA was used to perform targeted gene capture using a custom capture kit. Libraries were sequenced to mean &gt;80-100X coverage on Illumina sequencing platform. Sequence obtained were aligned to human references genome using BWA program and analyzed using Picard and GATK-Lite toolkit to identify variants in the targeted genes relevant to clinical indication.</Description>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0032467" />
              </Trait>
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0000568" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="CHRNA3">
              <Name>cholinergic receptor nicotinic alpha 3 subunit</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000743.5:exon 5</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>p.Cys173TyrfsTer11</Name>
          </OtherNameList>
          <FunctionalConsequence Value="Unknown function" />
          <AttributeSet>
            <Attribute Type="HGVS">NM_000743.5:c.518_519del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="191800" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12326571</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5397033" TraitType="Disease" MappingType="XRef" MappingValue="191800" MappingRef="OMIM">
        <MedGen CUI="C5231389" Name="Urinary bladder, atony of" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5397033" TraitType="Finding" MappingType="XRef" MappingValue="HP:0000568" MappingRef="HP">
        <MedGen CUI="C0026010" Name="Microphthalmia" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5397033" TraitType="Finding" MappingType="XRef" MappingValue="HP:0032467" MappingRef="HP">
        <MedGen CUI="C5139363" Name="Past obstetric history" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

